Stocks Amgen Inc

More

  • graphic_word_ofthe_street.jpg

    The Dow rallied for a second day on Friday on hopes Washington's stimulus package and a bank rescue plan will bolster the ailing economy.

  • graphic_word_ofthe_street.jpg

    Stocks ended higher Tuesday, snapping a three-day losing streak, after strong earnings from Merck and a better-than-expected housing report lifted sentiment on the Street.

  • The health care sector today just went positive for 2009, making it the only major industry group to currently be in the green for this young year.

  • graphic_word_ofthe_street.jpg

    The Dow and S&P 500 fell on Monday as uncertainty about the Obama administration's plan to stem bank losses dragged down financial shares.

  • Call options are heating up in Amgen, which is up slightly Monday in a sluggish market. As AMGN trades at about $55.20 the Febuary 57.5 and 60 calls are drawing a few nibbles, but most of today's action involves the Febuary 65 calls. What's it mean?

  • graphic_fast_money.jpg

    Thomas writes, "Is it time to short the XLF? " Also Yog asks, "what are the traders thoughts on Amgen after their earnings report?"

  • graphic_word_ofthe_street.jpg

    Stocks climbed on Tuesday, with the S&P 500 and the Nasdaq up for a third straight day after encouraging news on the earnings front...

  • Investors can’t help but wonder what’s the best way to play Pharma after Pfizer said it would buy rival Wyeth for $60 billion, a 20% premium!

  • webxtra_thumb.jpg

    In this Web Extra, the traders reveal how they're gaming earnings from McDonald's, Amgen, Caterpillar, Starbucks as well as the Fed Meeting and much more!

  • johnson_johnson2_logo.jpg

    Dow component and giant healthcare company--you really can't lump it in with big pharma because it sells drugs, medical devices and consumer products--Johnson & Johnson reported earnings this morning.

  • Some call it the Super Bowl of healthcare. We’re talking about the JP Morgan Healthcare Conference kicking off Monday and it could move stocks.

  • Following are the year’s biggest winners and losers. Find out why shares of McDonald’s and Gilead Sciences popped while General Motors and Citigroup dropped.

  • BlackRock vice chairman and global chief investment officer of equities Bob Doll says it's time to re-introduce risk into portfolios.

  • The week ended with a stunningly bad November jobs report, indicating that the economy is getting much worse much faster than expected, and suggesting that the recession will be especially deep and prolonged.   It was a grim end to a volatile week, beginning with a huge loss on Monday, but CNBC guests continued to encourage investors to buy stocks, saying now is the time to position oneself for the recovery and take advantage of valuations.

  • The stock market was far off its morning lows, coming close to turning positive, as investors shook off a handful of weak economic reports and snapped up biotech shares and other defensive plays.

  • pharma_new2.jpg

    Look for M&A activity—big and small—a pair of breakthrough drugs and the prospect of government price controls.

  • The Thanksgiving-week rally took the markets up 10 percent, and with a 28-percent gain, financials outperformed just about everything else.  BlackRock's Bob Doll sees investors cashing in on those gains this week, and recommends a move to more defensive stocks.

  • One of the weapons widely used to fight cholesterol might be more powerful than previously believed. Is there a trade here?

  • AMGEN

    While on the elliptical at the gym the other night I was watching one network newscast and the person on the machine next to me was watching another one.